Detalhe da pesquisa
1.
Hospital-based surveillance of severe paediatric malaria in two malaria transmission ecological zones of Burkina Faso.
Malar J
; 22(1): 6, 2023 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36609299
2.
Household costs and time to treatment for children with severe febrile illness in rural Burkina Faso: the role of rectal artesunate.
Malar J
; 17(1): 380, 2018 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30348157
3.
A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults.
J Clin Invest
; 134(7)2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290009
4.
Understanding and maximising the community impact of seasonal malaria chemoprevention in Burkina Faso (INDIE-SMC): study protocol for a cluster randomised evaluation trial.
BMJ Open
; 14(3): e081682, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38479748
5.
Contribution of the Rapid LAMP-Based Diagnostic Test (RLDT) to the Evaluation of Enterotoxigenic Escherichia coli (ETEC) and Shigella in Childhood Diarrhea in the Peri-Urban Area of Ouagadougou, Burkina Faso.
Microorganisms
; 11(11)2023 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38004821
6.
Malariometric Indices in the Context of Seasonal Malaria Chemoprevention in Children Aged 1.5 to 12 Years during the Period of High Malaria Transmission in the Suburban Area of Banfora, Burkina Faso.
Trop Med Infect Dis
; 8(9)2023 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37755903
7.
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial.
Front Immunol
; 14: 1267372, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37908361
8.
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children.
Front Immunol
; 13: 978591, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36119062
9.
Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial.
PLoS Med
; 8(2): e1000408, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21304925
10.
PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study.
Lancet Infect Dis
; 20(5): 585-597, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32032566
11.
The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum.
Malar J
; 8: 48, 2009 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19291301
12.
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.
PLoS One
; 13(12): e0208328, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30540808
13.
Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.
PLoS One
; 6(8): e23391, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21858097
14.
Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthetic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa.
Vaccine
; 25(14): 2723-32, 2007 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-17280744